Published in Arch Gen Psychiatry on June 01, 2011
Comparative neuropharmacology of three psychostimulant cathinone derivatives: butylone, mephedrone and methylone. Br J Pharmacol (2012) 1.49
Sustained recreational use of ecstasy is associated with altered pre and postsynaptic markers of serotonin transmission in neocortical areas: a PET study with [¹¹C]DASB and [¹¹C]MDL 100907. Neuropsychopharmacology (2012) 0.97
Evidence for chronically altered serotonin function in the cerebral cortex of female 3,4-methylenedioxymethamphetamine polydrug users. Arch Gen Psychiatry (2011) 0.89
MDMA and 5-HT neurotoxicity: the empirical evidence for its adverse effects in humans - no need for translation. Br J Pharmacol (2012) 0.84
Verbal memory deficits are correlated with prefrontal hypometabolism in (18)FDG PET of recreational MDMA users. PLoS One (2013) 0.83
3,4-methylenedioxymethamphetamine (MDMA): current perspectives. Subst Abuse Rehabil (2013) 0.78
Psychiatric profiles of mothers who take Ecstasy/MDMA during pregnancy: reduced depression 1 year after giving birth and quitting Ecstasy. J Psychopharmacol (2013) 0.78
The effects of ecstasy on neurotransmitter systems: a review on the findings of molecular imaging studies. Psychopharmacology (Berl) (2016) 0.75
Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms. Sci Rep (2017) 0.75
Separating the agony from ecstasy: R(-)-3,4-methylenedioxymethamphetamine has prosocial and therapeutic-like effects without signs of neurotoxicity in mice. Neuropharmacology (2017) 0.75
Consensus nomenclature for in vivo imaging of reversibly binding radioligands. J Cereb Blood Flow Metab (2007) 11.79
HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J Neurovirol (2010) 7.56
Distinct genetic influences on cortical surface area and cortical thickness. Cereb Cortex (2009) 3.90
Development of cortical and subcortical brain structures in childhood and adolescence: a structural MRI study. Dev Med Child Neurol (2002) 3.39
The bilingual effect on Boston Naming Test performance. J Int Neuropsychol Soc (2007) 2.74
Diffusion tensor imaging during recovery from severe traumatic brain injury and relation to clinical outcome: a longitudinal study. Brain (2007) 2.59
Neuroanatomical assessment of biological maturity. Curr Biol (2012) 2.40
Hierarchical genetic organization of human cortical surface area. Science (2012) 2.28
MR-based automatic delineation of volumes of interest in human brain PET images using probability maps. Neuroimage (2004) 2.07
Quantitative evaluation of automated skull-stripping methods applied to contemporary and legacy images: effects of diagnosis, bias correction, and slice location. Hum Brain Mapp (2006) 2.06
The basics of brain development. Neuropsychol Rev (2010) 1.92
Is the prefrontal cortex necessary for establishing cognitive sets? J Neurosci (2007) 1.88
A technique for the deidentification of structural brain MR images. Hum Brain Mapp (2007) 1.87
Regional brain shape abnormalities persist into adolescence after heavy prenatal alcohol exposure. Cereb Cortex (2002) 1.74
Mapping sulcal pattern asymmetry and local cortical surface gray matter distribution in vivo: maturation in perisylvian cortices. Cereb Cortex (2002) 1.73
Blood BDNF concentrations reflect brain-tissue BDNF levels across species. Int J Neuropsychopharmacol (2010) 1.67
Correlation of in vivo neuroimaging abnormalities with postmortem human immunodeficiency virus encephalitis and dendritic loss. Arch Neurol (2004) 1.65
Evaluation of the Serotonin Transporter Ligand 123I-ADAM for SPECT Studies on Humans. J Nucl Med (2008) 1.60
Feasibility of multi-site clinical structural neuroimaging studies of aging using legacy data. Neuroinformatics (2007) 1.59
White matter tract injury and cognitive impairment in human immunodeficiency virus-infected individuals. J Neurovirol (2009) 1.57
Integrated software for the analysis of brain PET/SPECT studies with partial-volume-effect correction. J Nucl Med (2004) 1.56
Longitudinal characterization of white matter maturation during adolescence. Brain Res (2010) 1.55
Species differences in blood-brain barrier transport of three positron emission tomography radioligands with emphasis on P-glycoprotein transport. Drug Metab Dispos (2008) 1.50
Multimodal imaging of the self-regulating developing brain. Proc Natl Acad Sci U S A (2012) 1.49
Genetic topography of brain morphology. Proc Natl Acad Sci U S A (2013) 1.46
Genetic influences on cortical regionalization in the human brain. Neuron (2011) 1.46
Analgesic effect of perioperative escitalopram in high pain catastrophizing patients after total knee arthroplasty: a randomized, double-blind, placebo-controlled trial. Anesthesiology (2015) 1.44
Long-term global and regional brain volume changes following severe traumatic brain injury: a longitudinal study with clinical correlates. Neuroimage (2008) 1.40
Mapping cortical gray matter asymmetry patterns in adolescents with heavy prenatal alcohol exposure. Neuroimage (2002) 1.39
Measurements of brain-derived neurotrophic factor: methodological aspects and demographical data. Brain Res Bull (2007) 1.35
Brain morphometry in female victims of intimate partner violence with and without posttraumatic stress disorder. Biol Psychiatry (2002) 1.33
When does brain aging accelerate? Dangers of quadratic fits in cross-sectional studies. Neuroimage (2010) 1.33
The relationship between cerebral blood flow and volume in humans. Neuroimage (2005) 1.29
Radiosynthesis and in vivo evaluation of a series of substituted 11C-phenethylamines as 5-HT (2A) agonist PET tracers. Eur J Nucl Med Mol Imaging (2010) 1.27
Preclinical safety assessment of the 5-HT2A receptor agonist PET radioligand [ 11C]Cimbi-36. Mol Imaging Biol (2013) 1.25
Distribution patterns, dermatomal anesthesia, and ropivacaine serum concentrations after bilateral dual transversus abdominis plane block. Reg Anesth Pain Med (2012) 1.21
European multicentre database of healthy controls for [123I]FP-CIT SPECT (ENC-DAT): age-related effects, gender differences and evaluation of different methods of analysis. Eur J Nucl Med Mol Imaging (2012) 1.19
White matter microstructure in superior longitudinal fasciculus associated with spatial working memory performance in children. J Cogn Neurosci (2010) 1.18
Measuring endogenous 5-HT release by emission tomography: promises and pitfalls. J Cereb Blood Flow Metab (2010) 1.16
Frontolimbic serotonin 2A receptor binding in healthy subjects is associated with personality risk factors for affective disorder. Biol Psychiatry (2007) 1.15
Cluster analysis in kinetic modelling of the brain: a noninvasive alternative to arterial sampling. Neuroimage (2004) 1.14
Genetic and environmental contributions to regional cortical surface area in humans: a magnetic resonance imaging twin study. Cereb Cortex (2011) 1.13
A comparison of heritability maps of cortical surface area and thickness and the influence of adjustment for whole brain measures: a magnetic resonance imaging twin study. Twin Res Hum Genet (2012) 1.13
Basal ganglia volumes in drug-naive first-episode schizophrenia patients before and after short-term treatment with either a typical or an atypical antipsychotic drug. Psychiatry Res (2007) 1.11
5-HT radioligands for human brain imaging with PET and SPECT. Med Res Rev (2011) 1.10
Brain development during the preschool years. Neuropsychol Rev (2012) 1.09
Salivary cortisol and prefrontal cortical thickness in middle-aged men: A twin study. Neuroimage (2010) 1.09
Development of a (11)C-labeled tetrazine for rapid tetrazine-trans-cyclooctene ligation. Chem Commun (Camb) (2013) 1.08
The 5-HT1A serotonin receptor is located on calbindin- and parvalbumin-containing neurons in the rat brain. Brain Res (2003) 1.08
[123I]epidepride binding to cerebellar dopamine D2/D3 receptors is displaceable: implications for the use of cerebellum as a reference region. Neuroimage (2006) 1.06
Early detection of response to experimental chemotherapeutic Top216 with [18F]FLT and [18F]FDG PET in human ovary cancer xenografts in mice. PLoS One (2010) 1.06
Presence of ApoE ε4 allele associated with thinner frontal cortex in middle age. J Alzheimers Dis (2011) 1.05
Depression and Alzheimer's disease: is stress the initiating factor in a common neuropathological cascade? J Alzheimers Dis (2011) 1.04
Quantitative PET of human urokinase-type plasminogen activator receptor with 64Cu-DOTA-AE105: implications for visualizing cancer invasion. J Nucl Med (2012) 1.04
[18F]FDG and [18F]FLT positron emission tomography imaging following treatment with belinostat in human ovary cancer xenografts in mice. BMC Cancer (2013) 1.03
A database of [(18)F]-altanserin binding to 5-HT(2A) receptors in normal volunteers: normative data and relationship to physiological and demographic variables. Neuroimage (2004) 1.03
Neurovascular coupling to D2/D3 dopamine receptor occupancy using simultaneous PET/functional MRI. Proc Natl Acad Sci U S A (2013) 1.02
Accelerated cerebral white matter development in preterm infants: a voxel-based morphometry study with diffusion tensor MR imaging. Neuroimage (2008) 1.02
Left hippocampal volume loss in Alzheimer's disease is reflected in performance on odor identification: a structural MRI study. J Int Neuropsychol Soc (2003) 1.02
Methods for motion correction evaluation using 18F-FDG human brain scans on a high-resolution PET scanner. J Nucl Med (2012) 1.02
Seasonal changes in brain serotonin transporter binding in short serotonin transporter linked polymorphic region-allele carriers but not in long-allele homozygotes. Biol Psychiatry (2010) 1.00
α4βδ GABA(A) receptors are high-affinity targets for γ-hydroxybutyric acid (GHB). Proc Natl Acad Sci U S A (2012) 0.99
The challenge of connecting the dots in the B.R.A.I.N. Neuron (2013) 0.99
High tumor uptake of (64)Cu: implications for molecular imaging of tumor characteristics with copper-based PET tracers. Nucl Med Biol (2013) 0.99
Brain imaging of serotonin 4 receptors in humans with [11C]SB207145-PET. Neuroimage (2010) 0.98
Laser Doppler flowmetry is valid for measurement of cerebral blood flow autoregulation lower limit in rats. Exp Physiol (2005) 0.98
Decreased frontal serotonin2A receptor binding in antipsychotic-naive patients with first-episode schizophrenia. Arch Gen Psychiatry (2010) 0.98
Quantification of 5-HT2A receptors in the human brain using [18F]altanserin-PET and the bolus/infusion approach. J Cereb Blood Flow Metab (2003) 0.98
Early adolescent cortical thinning is related to better neuropsychological performance. J Int Neuropsychol Soc (2013) 0.97
Serotonin2A receptor blockade and clinical effect in first-episode schizophrenia patients treated with quetiapine. Psychopharmacology (Berl) (2010) 0.96
An incomplete TCA cycle increases survival of Salmonella Typhimurium during infection of resting and activated murine macrophages. PLoS One (2010) 0.96
Response inhibition is associated with white matter microstructure in children. Neuropsychologia (2009) 0.95
The brain 5-HT4 receptor binding is down-regulated in the Flinders Sensitive Line depression model and in response to paroxetine administration. J Neurochem (2009) 0.95
Patients with obsessive-compulsive disorder have increased 5-HT2A receptor binding in the caudate nuclei. Int J Neuropsychopharmacol (2005) 0.95
Association of common genetic variants in GPCPD1 with scaling of visual cortical surface area in humans. Proc Natl Acad Sci U S A (2012) 0.95
68Ga-labeling and in vivo evaluation of a uPAR binding DOTA- and NODAGA-conjugated peptide for PET imaging of invasive cancers. Nucl Med Biol (2011) 0.95
Cognitive testing of pigs (Sus scrofa) in translational biobehavioral research. Neurosci Biobehav Rev (2010) 0.94
The personality trait openness is related to cerebral 5-HTT levels. Neuroimage (2008) 0.94
Genetic patterns of correlation among subcortical volumes in humans: results from a magnetic resonance imaging twin study. Hum Brain Mapp (2011) 0.94
Mass dose effects and in vivo affinity in brain PET receptor studies--a study of cerebral 5-HT4 receptor binding with [11C]SB207145. Nucl Med Biol (2011) 0.94